Neil Chatterji
Stock Analyst at B. Riley Securities
(1.72)
# 3,297
Out of 5,072 analysts
19
Total ratings
29.41%
Success rate
4.14%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $14.46 | +93.64% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $15.38 | -15.47% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $68.01 | -26.48% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.04 | +621.15% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $25.95 | -30.64% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $5.80 | -22.41% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.04 | +236.54% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.43 | +126.34% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $3.08 | +208.44% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $14.46
Upside: +93.64%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $15.38
Upside: -15.47%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $68.01
Upside: -26.48%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.04
Upside: +621.15%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $25.95
Upside: -30.64%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $5.80
Upside: -22.41%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.04
Upside: +236.54%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.43
Upside: +126.34%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $3.08
Upside: +208.44%